Trials / Unknown
UnknownNCT04223895
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
Phase I Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-386 With Co-administration of D012, D326, and D337 in Healthy Adult Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the pharmacokinetics and Safety/Tolerability of CKD-386
Detailed description
Phase I clinical trial to compare the pharmacokinetics and tolerability of CKD-386 with co-administration of D012, D326, and D337 in healthy adult volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-386 Formulation 1 | A single oral dose of 1 tablet under fasting conditions for each period |
| DRUG | CKD-386 Formulation 2 | A single oral dose of 1 tablet under fasting conditions for each period |
| DRUG | D012, D326 and D337 | A single oral dose of 3 tablets(D012, D326 and D337) under fasting conditions for each period |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2020-03-04
- Completion
- 2020-06-15
- First posted
- 2020-01-10
- Last updated
- 2020-01-10
Source: ClinicalTrials.gov record NCT04223895. Inclusion in this directory is not an endorsement.